Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Bosman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Stem Cells Translational Medicine|March 25, 2017
Turning Potential Into Action: Using Pluripotent Stem Cells to Understand Heart Development and Function in Health and DiseaseHananeh Fonoudi, Alexis Bosman
Theriogenology|November 1, 2006
Derivation of human embryonic stem cell linesTeija T Peura, Alexis Bosman, Tomas Stojanov
Stem Cell Research|June 28, 2016
Derivation of human embryonic stem cell line Genea022Biljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Stem Cell Research|June 28, 2016
Derivation of Genea002 human embryonic stem cell lineBiljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Stem Cell Research|June 28, 2016
Derivation of Trisomy 21 affected human embryonic stem cell line Genea021Biljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Stem Cell Research|June 28, 2016
Derivation of human embryonic stem cell line Genea023Biljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Cloning and Stem Cells|April 5, 2008
Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryosTeija Peura, Alexis Bosman, Omar Chami, et al.
Molecular Carcinogenesis|December 18, 2015
Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoterJames Blackburn, Daniel L Roden, Robert Ng, et al.
Stem Cells International|February 17, 2016
Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety IssuesCarmen Unzu, Marc Friedli, Alexis Bosman, et al.
Journal of Clinical Medicine|August 5, 2015
Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart DiseaseAlexis Bosman, Michael J Edel, Gillian Blue, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Stem Cells Translational Medicine|March 25, 2017
Turning Potential Into Action: Using Pluripotent Stem Cells to Understand Heart Development and Function in Health and DiseaseHananeh Fonoudi, Alexis Bosman
Theriogenology|November 1, 2006
Derivation of human embryonic stem cell linesTeija T Peura, Alexis Bosman, Tomas Stojanov
Stem Cell Research|June 28, 2016
Derivation of human embryonic stem cell line Genea022Biljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Stem Cell Research|June 28, 2016
Derivation of Genea002 human embryonic stem cell lineBiljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Stem Cell Research|June 28, 2016
Derivation of Trisomy 21 affected human embryonic stem cell line Genea021Biljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Stem Cell Research|June 28, 2016
Derivation of human embryonic stem cell line Genea023Biljana Dumevska, Alexis Bosman, Robert McKernan, et al.
Cloning and Stem Cells|April 5, 2008
Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryosTeija Peura, Alexis Bosman, Omar Chami, et al.
Molecular Carcinogenesis|December 18, 2015
Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoterJames Blackburn, Daniel L Roden, Robert Ng, et al.
Stem Cells International|February 17, 2016
Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety IssuesCarmen Unzu, Marc Friedli, Alexis Bosman, et al.
Journal of Clinical Medicine|August 5, 2015
Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart DiseaseAlexis Bosman, Michael J Edel, Gillian Blue, et al.
Pageof 2